NSE ScannerFMCG & Food · Household/Personal Care · NSE: PGHH · data 2026-10-31
Procter & Gamble Hygiene & Health Care Ltd.
In plain words
Price: 49.2% below its 52-week high of ₹13,496.
Delivery: 46.9% of traded shares were kept for delivery over the last 10 sessions, against 54.5% over the last 60.
A description of the data, not a recommendation.
Key figures
Growth
| Revenue (last 12 months) | ₹4,245 cr |
| Net profit (last 12 months) | ₹791 cr |
| Sales growth, 3 years (yearly) | 3.2% |
| Profit growth, 3 years (yearly) | 14.2% |
At a glance
Promoters 70.6% (unchanged in a year), pledged 0.0%, institutions 15.7%.
P/E 28.1, dividend yield 3.4%. Price relative to earnings and book value (low is cheaper, not better).
ROE 114.9%, ROCE 134.7%, operating margin 24.4%: how much profit it earns on the money it uses.
Debt/equity 0.00, Profit growth 14.2% and sales growth 3.2% a year over 3 years.
Ratings use fixed thresholds on the latest reported figures. They describe the numbers and are not a recommendation.
Strengths and limitations
- Virtually debt-free (debt/equity 0.1 or less).
- High return on equity (114.9%).
- Healthy operating margin (24.4%).
- Pays a dividend yielding 3.4%.
- Slow sales growth (3.2% a year over 3 years).
Picked automatically from the latest reported figures with fixed rules; check the company's filings before relying on them.
Smart-money activity
12/100 · Weak over the last ~60 sessions, data 2026-10-30
- Delivery vs usual 0/30: Delivery 49.1% over the last 20 sessions vs 57.3% in the 40 before (0.86x); shares delivered per day 0.54x usual; 0 delivery-spike days (3x usual shares delivered, 40%+ delivery) in the last 20 sessions.
- Bulk/block deals 0/20: No bulk or block deals in the last 90 days.
- Insider / SAST buys 0/15: No insider buy or SAST acquisition filings in the last 90 days. Insider sells are not collected by the site, so only buy filings count.
- Mutual fund holding 7/15: 4 schemes hold it, about ₹864 cr in all (as of 2026-09-30). Latest monthly portfolios only (top 60 holdings per scheme); month-on-month change is not stored.
- Accumulation evidence 0/15: No accumulation evidence row (only saved-scan stocks have one; 0 points).
- Promoter pledges 5/5: No promoter pledge filings in 90 days.
A description of recorded activity (delivery, deals, insider buys, fund holding, pledges), not a recommendation. Today's most active stocks.
Story so far
● Dividend
- 1 Sept 26Dividend Dividend ₹60 (ex-date) -2.7% next session
- 5 Feb 26Dividend Dividend ₹170 (ex-date) -0.9% next session
- 28 Aug 25Dividend Dividend ₹65 (ex-date) -0.2% next session
- 20 Feb 25Dividend Dividend ₹110 (ex-date) -2.1% next session
- 19 Nov 24Dividend Dividend ₹95 (ex-date) +1.1% next session
From official exchange filings and NSE data. How the price moved after an event describes the past, not what comes next.
Shareholding trend
| Holder | Sept 2026 | Jun 2026 | Mar 2026 | Dec 2025 |
|---|---|---|---|---|
| Promoters | 70.64% | 70.64% | 70.64% | 70.64% |
| Foreign institutions (FII) | 0.62% | 0.98% | 0.97% | 1.07% |
| Domestic institutions (DII) | 15.04% | 15.59% | 15.97% | 16.04% |
| Mutual funds | 7.41% | 8.00% | 8.65% | 8.81% |
| Retail investors | 10.34% | 9.64% | 9.40% | 9.29% |
| Number of shareholders | 64,415 | 57,957 | 53,416 | 50,969 |
Common questions
How much do promoters hold in Procter & Gamble Hygiene & Health Care Ltd.?
Promoters held 70.64% of Procter & Gamble Hygiene & Health Care Ltd. at the end of Sept 2026, with 0.00% of promoter shares pledged.
Is Procter & Gamble Hygiene & Health Care Ltd. debt-free?
Its latest reported debt-to-equity ratio is 0, so it carries little or no borrowing on the balance sheet.
What is Procter & Gamble Hygiene & Health Care Ltd.'s P/E ratio?
About 28.1, based on the last 12 months' earnings and a price of ₹6,851 (data 2026-10-31).
What is the 52-week high and low of Procter & Gamble Hygiene & Health Care Ltd.?
The 52-week high is ₹13,496 and the 52-week low is ₹6,579.
Mutual funds holding Procter & Gamble Hygiene & Health Care Ltd.
From the monthly portfolios of the fund houses the site reads, as of 2026-09-30. 4 schemes holding about ₹864 cr; funds that hold it outside their top holdings may not be listed.
| Scheme | Fund house | % of fund | Value |
|---|---|---|---|
| SBI Focused Fund | SBI Mutual Fund | 1.22% | ₹612 cr |
| SBI Midcap Fund | SBI Mutual Fund | 0.91% | ₹212 cr |
| ADITYA BIRLA SUN LIFE MNC FUND | Aditya Birla Sun Life Mutual Fund | 1.19% | ₹36 cr |
| Nippon India MNC Fund | Nippon India Mutual Fund | 1.02% | ₹4 cr |
Compared with similar companies
| Company | Price | Market cap | P/E | P/B | ROE | ROCE | Debt/eq. | 1-yr return |
|---|---|---|---|---|---|---|---|---|
| Procter & Gamble Hygiene & Health Care Ltd. | ₹6,851 | ₹22,253 cr | 28.1 | — | 114.9% | 134.7% | 0 | -49.1% |
| Dabur India Limited | ₹365.6 | ₹64,927 cr | 32.9 | — | 17.1% | 16.1% | 0.11 | -28.5% |
| Cupid Limited | ₹324.55 | ₹43,641 cr | 323.7 | — | 27.3% | 26.5% | 0.13 | +571.4% |
| Colgate-Palmolive (India) Limited | ₹1,596.5 | ₹43,374 cr | 31.9 | 26.8 | 81.6% | 103.4% | 0.03 | -30.0% |
| Gillette India Limited | ₹7,077 | ₹23,085 cr | 34.5 | — | 66.4% | 81.3% | 0 | -22.4% |
| Emami Limited | ₹359.75 | ₹15,800 cr | 21 | — | 27.6% | 27.5% | 0.06 | -33.7% |
Compare PGHH with DABUR in detail →
The full analysis has the price chart, every quarterly result with YoY/QoQ growth, the balance sheet and cash flow with an accounting red-flag check, shareholding quarter by quarter with big investors, news, filings and bulk/block deals.
Open PGHH in NSE Scanner →